{"name":"Biocon Limited","slug":"biocon-limited","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"oncology","drugs":[{"name":"Humulin®R","genericName":"Humulin®R","slug":"humulinr","indication":"Other","status":"marketed"},{"name":"Biocon's Human Insulin R U-500","genericName":"Biocon's Human Insulin R U-500","slug":"biocon-s-human-insulin-r-u-500","indication":"Other","status":"phase_1"},{"name":"Insulin Lispro Injection","genericName":"Insulin Lispro Injection","slug":"insulin-lispro-injection","indication":"Other","status":"marketed"},{"name":"Tregopil","genericName":"Tregopil","slug":"tregopil","indication":"Other","status":"discontinued"}]}],"pipeline":[{"name":"Humulin®R","genericName":"Humulin®R","slug":"humulinr","phase":"marketed","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Biocon's Human Insulin R U-500","genericName":"Biocon's Human Insulin R U-500","slug":"biocon-s-human-insulin-r-u-500","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Insulin Lispro Injection","genericName":"Insulin Lispro Injection","slug":"insulin-lispro-injection","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Tregopil","genericName":"Tregopil","slug":"tregopil","phase":"discontinued","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-04-08","type":"regulatory","source":"Devdiscourse","summary":"Biocon Pharma Secures USFDA Nod for Dapagliflozin Tablets - Devdiscourse","headline":"Biocon Pharma Secures USFDA Nod for Dapagliflozin Tablets","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxQMFJla09QMk1PMnVlQTJXY1ZtQkZycm9mZ2NsYmEySGR5NDFBQVc4TndkalA0ZVNYY1d6ZlotNm1BMVJNZDE4czBSRTBiNFJ6UndpQ2k1anFjYkJtbTB0S29HM1plTmJfOGg2eU1BM1lRYVhiRXYyc0FCbzZkSl9sa2NKRmNEM0lxaWlHeWpTV0pVY3pSQXRyUElSenpGLXBVZTV3ZVFDd0NSMWp1dEY1RUs3c2pJWXNfTVgtdGc2cEJpVHNBMzI1MDEwRQ?oc=5","date":"2026-04-08","type":"regulatory","source":"scanx.trade","summary":"Biocon Pharma Limited Receives US FDA Approval for Dapagliflozin Tablets - scanx.trade","headline":"Biocon Pharma Limited Receives US FDA Approval for Dapagliflozin Tablets","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxPMWRTMGwyWEdFWDJWcmRrRjdDZTRqRzBSLTFSMzU4WDl5eEQ2UTg5QXlaUU9TX1N6ZFJxRXV3LTRhWVlOUzNzRmh3cHJ0Q2VOZEV3MWpuVS1BOERKM2ZmVVMza01QTmwxbkVCUE1Zc1lXU3RLUDNDYUl6TU9ENnhuT2l2dnY2d1o3blBhUm1PYXd6VVh3U0dicGxLZDZ3VDN30gGmAUFVX3lxTE8xVkZFTDhSbzQ0bHc3Q3ZUVlNDV2FMUWs2U2NJN3ctNHdCcFZDeXlsOTdFZVItanYtelBPWVJITnl3cVkzZXZSU0VOdjY1QmRqVWIzakZFTmJmU09ucF9aOTJUdVN2QkJVblpwZXV0N2xhbmppd1dORVdabHJJaDBneFVtRUxzZmlENTBTS1JzbGpybHg3WDg1SXhzQzQ4cThTaC1XclE?oc=5","date":"2026-04-08","type":"regulatory","source":"Rediff MoneyWiz","summary":"Biocon Gets USFDA Nod for Dapagliflozin Tablets - Rediff MoneyWiz","headline":"Biocon Gets USFDA Nod for Dapagliflozin Tablets","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-04-04","type":"patent","source":"The Economic Times","summary":"Trump's 100% tariff on patented drugs has limited impact on Indian pharma, rising protectionism a concern: - The Economic Times","headline":"Trump's 100% tariff on patented drugs has limited impact on Indian pharma, rising protectionism a concern:","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxQWHAzMTFMVmxIR0RKM2RKZkp5ZHQxSGVxWVdheHktZnJwbDJRWGU4Z3pITUh3Ri1JVVFlWjE3c1VtRE9QdjFfVjZkdURLNng1ZnVicW1GMThUdmd6aXFRUDFCVGpkNmg4c3FsbVpjQW02QkktdFdNX0JTa2laUWF1VmR5QUlHYTRXcjJsSkRpaFlRVzVnd0toR0JxYjE2OTFt?oc=5","date":"2026-03-27","type":"pipeline","source":"Contract Pharma","summary":"Biocon Names Shreehas Tambe CEO and Managing Director - Contract Pharma","headline":"Biocon Names Shreehas Tambe CEO and Managing Director","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxNY3RLaVR3b3VDM2F5cVN4akpoSGgwRFp3b3hwNDhvb2tTWEl1QnJmSmtudGFDMTlTMFdvSkdZdjRtTGgybFIxa3dTdjFZU2tpM3lVV3YwSFVSbkp2UG1TdFFjQ1EwSEVvWFJ1YVZuanhiM2dCTE1VaERMN3QzMEpFVFNLeDJjenNFdFY2MkNMU1dOVko5RmdWVEl0eVdSZ9IBogFBVV95cUxQSXFnekhZUUlUMGNIaHpJZ1lTSjNpcWI0LVVDTTVNT3ptc0lBVWdzSzNHSC1WemhWY2tyUjdfZEFmeWxsRjJaalRCREVQd3dvdVN1T00xTEJ4S1R5ckJGdkNUOFU3Qy1kZmFwMkpwcVFFRzdTR0VrN1B6VjNlVUtydzNrbDU5azlxNjNEMUtZMW1vOWhZckIyQi1QLW1EOThqZmc?oc=5","date":"2026-03-27","type":"pipeline","source":"Tribune India","summary":"Pharma giant Biocon appoints Shreehas Tambe as CEO & MD - Tribune India","headline":"Pharma giant Biocon appoints Shreehas Tambe as CEO & MD","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxQcXMzUVh6bktvN0s4YURpVm0wNS1meHdfM013Vk5PbU5NQk9MWUVMZU5yNnpWWnViN18xcGRDaUlPbU1CNWU2bkIxOVpLMlV2NzRvWk1oMFhtNDl2X3hhMUZoX1RWbm15TEE5M2dYckdBSmtIbmFjeHBkTU9oOHZxLTFlcFRiZ1ViSWhxUFRweGNxaGx4WXdDY0Q4ekVCUS1QcWg5eGdFLWw4WXkyWlQ5cmpZaFo3ZXNrNUJ5dDFFWEM?oc=5","date":"2026-03-03","type":"pipeline","source":"TipRanks","summary":"Biocon bolsters pharma subsidiaries with fresh preference share funding - TipRanks","headline":"Biocon bolsters pharma subsidiaries with fresh preference share funding","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxOTmc1VFE1dzZBOVowWmE2WXJqeVJyMmMtZGxwS0ZpMEY3SnFvNHZJNnVHR0xMMmFaQkk5RmZnN0ljV1dHU0VULVZDbWxvV055N3dHUDduaU81RDN5cXh5dkFMWlB1Wk1VeFg3UVVnY0ltb2hOOFNHNXRXUmxTanU5bjdYZmNzN242RTRkRktTMGVIVXI4bGZfTXFJSGFSZHVtRkZpXzJ1OVVXOG4yakZiVjhUVllHVFBmb0dJUWVlckNUbkVRNmpkVEhQU09kQlpMWGc?oc=5","date":"2026-02-16","type":"earnings","source":"Reuters","summary":"Biocon aims for revenue surge with rollout of generic weight-loss drugs - Reuters","headline":"Biocon aims for revenue surge with rollout of generic weight-loss drugs","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxPbF8yZUFyeFUtT2VTejBVSDM3SnVIM0RUbnU3UklkZVkxWWs2UFpCMkNvalk1RUJEVjhEamxyMkNpeXdjcVRMbVFIdGVFNHJtTUhuczBsUG9DOWJGQzJGNnRfNU9JaGQwdHFJdU12eDRZSGs0U3c1ZG9kemEySXNPcmFPVllqQUx5WGoxajFrRzd5Zw?oc=5","date":"2025-12-09","type":"pipeline","source":"The Pharma Letter","summary":"Biocon Limited to integrate Biocon Biologics - The Pharma Letter","headline":"Biocon Limited to integrate Biocon Biologics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxNTmhaY0E5dlZ2ZWJlcVgwTEFoRUU1UHJQUTRfbWczbGxvdnNLbXpQZGZ5NnFLcWQ5WFpXXzk3Rk81VU1ua3pDcm5aTTFWX0NCZGx6Zk1VdXFwLVZBemxYdk1OVkNJdnAySlJaVnlRdlNHUHJOZWUybkdRTUEyR29sM1F1TDlHeXNxbXFJYjAxNGw5Y1V3cWtVM1NNSUtwTXhNUDY1My1WU2k4aEI1UGRmTVRGOHYwMm01dzEzakRB?oc=5","date":"2025-12-09","type":"deal","source":"Fierce Pharma","summary":"Biocon buys out Viatris and others from biosimilar subsidiary - Fierce Pharma","headline":"Biocon buys out Viatris and others from biosimilar subsidiary","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxOX2ZmcjRzYndPekJPVXdENnR0RllpVWM5Y0VneXRjblRXVmVhel9lZzIxVkRkaXhVZEc3LS1mYmN6N3ZhQlRBUEhSck5GZlFFekRQd0JRamJKSWEtbVdHRW9nb05SRGF1V1NSX2NvdVhJVHluT0tnM2JIN1ROaHA2amlvYml3bE9FaWh5N1N2eDc1VzRVRUdHRUw2X1BPd9IBVkFVX3lxTE9ZYlRkbXliRkUyTzM2ZTRUeXpKaHlRR1VzbFA0RlZOQ1ZuQzlJNzY0MUFMbFBHS0ptRkZNTHk3MkZBTW1YV21VNnJDOGY2QjhOZTdoelpn?oc=5","date":"2025-11-14","type":"patent","source":"Law360","summary":"Biocon Challenges Regeneron Over UK Retinal Pharma Patent - Law360","headline":"Biocon Challenges Regeneron Over UK Retinal Pharma Patent - Law360","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxPX2tZN3dHdXduUHdwTVItU0w5d3lmOGdGby1VRzJMcXRCT0JDLVlxSThrWV80Zy1xT1A0aHM0WEo3OW02X2ZQdElfSTY2bW1hOFBvclhOOUtDT3VuS1FDaFR0M3Y3R1BsUE5PbHd2SmRGUFQ4eTRvUjNyVVN0WFZ1cXBSZjNMTEp0M0RJSThyMWc1Wk9lWG1FLUs2cUx4c2EzSXc?oc=5","date":"2025-09-12","type":"pipeline","source":"New Jersey Business Magazine","summary":"Biocon Inaugurates First US Manufacturing Facility in Cranbury - New Jersey Business Magazine","headline":"Biocon Inaugurates First US Manufacturing Facility in Cranbury","sentiment":"neutral"}],"patents":[],"drugCount":4,"phaseCounts":{"marketed":2,"phase_1":1,"discontinued":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}